COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Website maintenance The PDA website will be unavailable due to scheduled maintenance between 8:00 and 17:00 BST on Saturday 20th April 2024

Home  »   Coronavirus (COVID-19)Violence in PharmacyLatest News   »   PDA increase action on campaign to end violence in pharmacies

PDA increase action on campaign to end violence in pharmacies

Due to the rise in reported violent and unacceptable behaviour by patients, the PDA has issued a ‘zero tolerance’ poster for display in community pharmacies and has also raised the issue with the Home Office.

Mon 6th April 2020 The PDA

Employer action needed

Sadly, aggressive patient behaviour was already experienced before the COVID-19 crisis began and the zero tolerance of abuse measure is part of a long-running campaign by the PDA to end violence in pharmacy. However, given the increase in incidents, the PDA is now calling on pharmacy employers to implement the Violence in Pharmacy policy and let patients know that this is their position.

Employers have a strict legal duty to protect the health and safety of their staff at work, and while the blame for any incident sits firmly with the abuser/assailant, employers nevertheless need to do all they can to prioritise the safety of their employees by seeking to prevent incidents as well as acting appropriately if they do still occur. 

 

Law enforcement

In addition to calling on employers to act, the PDA has also written to Home Secretary Priti Patel (see below) calling for government support to raise the issue and take whatever measures are necessary to protect pharmacists, their teams and other patients from abuse and assault. The PDA believe that more awareness and support from the police and firm penalties in the courts for those who assault pharmacists is essential.

Previously, the PDA lobbied to ensure that community pharmacists are in the scope of the Assaults on Emergency Workers (Offences) Act 2018, which makes tougher penalties possible.

The PDA has already successfully engaged a number of police forces (read more) in supporting their campaign to end violence in pharmacies, including working with Police & Crime Commissioners to recognise and take action on the situation in community pharmacy.

 

Posters

The PDA has today released a poster emphasising zero tolerance of abuse in pharmacies which it encourages all members to print and display in their pharmacy. The awareness of this policy is key if patient behaviour is to be influenced.

Download the PDA poster here to display in your pharmacy:

thumbnail of Zero tolerance for abuse update

The PDA recognise that the National Pharmacy Association issued a similar poster to their members in January 2019, which we applaud. However, as many pharmacists are working for employers who are not members of NPA, our poster can be used in any pharmacy.  We trust that all employers will not only endorse the posters being displayed but also strictly enforce the policy of ZERO TOLERANCE of abuse across the entire sector.

Download the content of the letter to Priti Patel here

thumbnail of Home Secretary letter

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)